Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 451, pseudogene (RNU6-451P) is a pseudogene related to the U6 small nuclear RNA (snRNA) family, which are components of the spliceosome complex responsible for the splicing of precursor mRNA. As a pseudogene, RNU6-451P does not encode a functional RNA molecule or protein product, and there is no evidence that it has a biological function, disease association, or is targeted by any known drugs. Its annotation reflects sequence similarity to the functional U6 snRNA genes but lacks the capacity to contribute to spliceosome assembly or catalytic activity[4]. Clarification: RNU6-451P is annotated as a pseudogene, not as a functional gene, receptor, enzyme, or therapeutic target. There appears to be no evidence of its use or study in pharmacology, disease biology, or molecular targeting fields. If you sought information about the functional U6 snRNA, refer to U6 small nuclear RNA (e.g., RNU6-1), but for RNU6-451P, only the pseudogene status applies[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 451, pseudogene (RNU6-451P).